EXPRESSION OF CELL ADHESION MOLECULES AND COMPLEMENT RECEPTORS IN DIAGNOSTICS OF TRANSPLANTED HEART REJECTION
https://doi.org/10.25207/1608-6228-2018-25-2-58-62
Abstract
Aim. Characterization of the changes in expression of cell adhesion molecules and complement receptors in the transplanted heart rejection using computer morphometry to improve the quality of endomyocardial biopsy diagnostics.
Materials and methods. Endomyocardial biopsies of 20 patients undergoing cardiac transplantation were used. Histological sections were stained using a standard procedure with hematoxylin and eosin, as well as an indirect immunohistochemical method with the ABC detection system against CD21 and CD31. The area of the positive reaction was estimated with computer morphometry.
Results. All biopsies are divided according to the degrees of rejection as follows: degree 0R – 8 samples, 1R – 10 samples, 2R – 7 samples, 3R – 4 samples. CD21 expression is 0.31% in samples with 0R, 1.09% at 1R, 2R rejection of 2.01%, and for 3R – 4.15%. The area occupied by CD31-positive cells is 3.49% in 0R, at 1R rejection this index decreases by 1.3 times, in biopsy samples with 2R this index is 1.8 times less, and for samples with 3R it decreases by 2.6 times.
Conclusion. Evaluation of CD21-positive cells in the myocardium allows us to predict cardiosclerosis, as well as a tendency to a chronic clinical course of the rejection. Expression of CD31 makes it possible to assess condition of the microcirculatory vessels in the graft, which is also important for the heart failure prevention.
About the Authors
A. A. VerevkinRussian Federation
Aleksandr A. Verevkin
4, Sedina str., Krasnodar, Russia, 350063
A. A. Slavinskiy
Russian Federation
4, Sedina str., Krasnodar, Russia, 350063
E. D. Kosmacheva
Russian Federation
4, Sedina str., Krasnodar, Russia, 350063
T. V. Stavenchuk
Russian Federation
1 Maya str., 167, Krasnodar, Russia, 350086
References
1. Urbanowicz T., Baszyńska-Wachowiak H., Ligowski M. et al. Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. Ann Transplant. 2014; 19: 295-99. DOI: http://dx.doi.org/10.20883/jms.2016.125.
2. Barbukhatti A.O, Kosmacheva E.D., Kizhvatova N.V. et al. First experience with heart transplantation in Krasnodar region. Russian journal of transplantology and artificial organs. 2014; 14 (3): 42-47. (In Russ., English abstract).
3. Vasichkina E.S., Mitrofanova L.B., Tatarsky R.B. et al. Endocardial biopsy in adults and pediatric patients. Journal of arrhythmology. 2014; 76: 37-40. (In Russ., English abstract).
4. Berry G.J., Angelini A, Burke M.M. et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005–2011). J Heart Lung Transplant. 2011; 30: 601-611. DOI: 10.1016/j.healun.2011.02.015.
5. Berry G.J., Burke M.M., Anderson C. et al: The 2013 International Society for Heart and Lung Transplantation Working Formulation for standardization of nomenclature in the pathologic diagnosis of antibody – mediated rejection in heart transplantation. J Heart Transplant. 2013; (32)12: 1147-61.
6. Verevkin A.A., Slavinskiy A.A., Kosmacheva E.D., Stavenchuk T.V. Pathomorphological signs of myocardium lesion in transplanted heart rejection. Kubanskij nauchnyj medicinskij vestnik. 2017; 24(6): 27-31. (In Russ., English abstract) DOI: 10.25207/1608-6228-2017-24-6-17-21.
7. Thorarinsdottir K, Camponeschi A, Cavallini N, Grimsholm O, Jacobsson L, Gjertsson I, Mårtensson I L. CD21(-/low) B cells in human blood are memory cells. Clin Exp Immunol. 2016; 185(2): 252-62. DOI: 10.1111/cei.12795.
8. Doi H., Tanoue S., Kaplan D.E. Peripheral CD27-CD21B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014; 150(2): 184-91. DOI: 10.1016/j.clim.2013.12.001.
9. Mitrevski M., Marrapodi R., Camponeschi A., Lazzeri C., Todi L., Quinti I., et al. Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells. Immunol Res. 2014; 60(2-3): 330-8. DOI: 10.1007/s12026014-8599-8.
10. Newman P.J., Berndt M.C., Gorski J., et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990; 247(4947): 1219-22.
11. Lertkiatmongkol P., Liao D., Mei H., Hu Y., Newman P.J. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol. 2016; 23(3): 253-9. DOI: 10.1097/MOH.0000000000000239.
12. Valentini X., Gossiaux A., Caron N., Nonclercq D., Legrand A., Toubeau G. Monoclonal antibody to CD31 (PECAM-1) inhibits tubular regeneration after ischemia reperfusion injury in the rat. Nephron Exp Nephrol. 2011; 118(3): e60-8. DOI: 10.1159/000322481.
13. Zakliczyński M., Lekston A., Swierad M., Wnek A., Buszman P., Przybylski R., et al. Coronary artery disease in heart transplant recipients – diagnosis and treatment. Single centre experience based on results of elective coronary angiography. Kardiol Pol. 2003; 58(2): 109-20.
Review
For citations:
Verevkin A.A., Slavinskiy A.A., Kosmacheva E.D., Stavenchuk T.V. EXPRESSION OF CELL ADHESION MOLECULES AND COMPLEMENT RECEPTORS IN DIAGNOSTICS OF TRANSPLANTED HEART REJECTION. Kuban Scientific Medical Bulletin. 2018;25(2):58-62. (In Russ.) https://doi.org/10.25207/1608-6228-2018-25-2-58-62